97 related articles for article (PubMed ID: 8746624)
1. Overexpression in Escherichia coli, folding, purification, and characterization of the first three short consensus repeat modules of human complement receptor type 1.
Dodd I; Mossakowska DE; Camilleri P; Haran M; Hensley P; Lawlor EJ; McBay DL; Pindar W; Smith RA
Protein Expr Purif; 1995 Dec; 6(6):727-36. PubMed ID: 8746624
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
Mossakowska D; Dodd I; Pindar W; Smith RA
Eur J Immunol; 1999 Jun; 29(6):1955-65. PubMed ID: 10382758
[TBL] [Abstract][Full Text] [Related]
3. Primary sequence of an alternatively spliced form of CR1. Candidate for the 75,000 M(r) complement receptor expressed on chimpanzee erythrocytes.
Birmingham DJ; Shen XP; Hourcade D; Nickells MW; Atkinson JP
J Immunol; 1994 Jul; 153(2):691-700. PubMed ID: 8021505
[TBL] [Abstract][Full Text] [Related]
4. Independently melting modules and highly structured intermodular junctions within complement receptor type 1.
Kirkitadze MD; Krych M; Uhrin D; Dryden DT; Smith BO; Cooper A; Wang X; Hauhart R; Atkinson JP; Barlow PN
Biochemistry; 1999 Jun; 38(22):7019-31. PubMed ID: 10353813
[TBL] [Abstract][Full Text] [Related]
5. Folding, calcium binding, and structural characterization of a concatemer of the first and second ligand-binding modules of the low-density lipoprotein receptor.
Bieri S; Atkins AR; Lee HT; Winzor DJ; Smith R; Kroon PA
Biochemistry; 1998 Aug; 37(31):10994-1002. PubMed ID: 9692993
[TBL] [Abstract][Full Text] [Related]
6. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
7. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
Furtado PB; Huang CY; Ihyembe D; Hammond RA; Marsh HC; Perkins SJ
J Mol Biol; 2008 Jan; 375(1):102-18. PubMed ID: 18028942
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of the functional fragment of pneumococcal surface protein A.
Jedrzejas MJ; Hollingshead SK; Lebowitz J; Chantalat L; Briles DE; Lamani E
Arch Biochem Biophys; 2000 Jan; 373(1):116-25. PubMed ID: 10620330
[TBL] [Abstract][Full Text] [Related]
9. Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli.
Johnson DL; Middleton SA; McMahon F; Barbone FP; Kroon D; Tsao E; Lee WH; Mulcahy LS; Jolliffe LK
Protein Expr Purif; 1996 Feb; 7(1):104-13. PubMed ID: 9172774
[TBL] [Abstract][Full Text] [Related]
10. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
11. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
[TBL] [Abstract][Full Text] [Related]
12. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli.
Banerji S; Day AJ; Kahmann JD; Jackson DG
Protein Expr Purif; 1998 Dec; 14(3):371-81. PubMed ID: 9882571
[TBL] [Abstract][Full Text] [Related]
15. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
[TBL] [Abstract][Full Text] [Related]
16. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
Kim KS; Sun ZY; Wagner G; Reinherz EL
J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
[TBL] [Abstract][Full Text] [Related]
17. Are trigger sequences essential in the folding of two-stranded alpha-helical coiled-coils?
Lee DL; Lavigne P; Hodges RS
J Mol Biol; 2001 Feb; 306(3):539-53. PubMed ID: 11178912
[TBL] [Abstract][Full Text] [Related]
18. Expression and refolding of functional fragments of the human lipopolysaccharide receptor CD14 in Escherichia coli and Pichia pastoris.
Majerle A; Kidric J; Jerala R
Protein Expr Purif; 1999 Oct; 17(1):96-104. PubMed ID: 10497074
[TBL] [Abstract][Full Text] [Related]
19. Use of Pichia pastoris for the expression, purification, and characterization of rat calretinin "EF-hand" domains.
Palczewska M; Groves P; Kuznicki J
Protein Expr Purif; 1999 Dec; 17(3):465-76. PubMed ID: 10600467
[TBL] [Abstract][Full Text] [Related]
20. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
